Journal Information
Vol. 2. Issue 1.
Pages 17-20 (January - February 1996)
Share
Share
Download PDF
More article options
Vol. 2. Issue 1.
Pages 17-20 (January - February 1996)
ARTIGO DE REVISÃO
Open Access
Tratamento da hipertensão arterial nos doentes com obstrução brônquica
Visits
4333
Salvador Saldanha Coelho*, Pedro Marques Silva**
* Assistente Eventual de Pneumologia do H.S. Marta, Serviço 1 do Hospital de Santa Marta (Dir.: Dr. F. Lacerda Nobre)
** Assistente Hospitalar de Medicina Interna do H.S. Marta, Serviço 1 do Hospital de Santa Marta (Dir.: Dr. F. Lacerda Nobre)
This item has received

Under a Creative Commons license
Article information
RESUMO

A hipertensão arterial e a obstrução brônquica são doenças muito comuns na população, não sendo raro portanto que coexistam no mesmo indivíduo. È fundamental tratar cada uma delas sem agravar a outra. No que respeita ao tratamento anti-hipertensor existem de facto medicamentos que agravam ou causam obstrução brônquica pelo que devem ser usados com precauções acrescidas ou ser contra-indicados.

Consideramos neste trabalho que na obstrução brônquica os anti-hipertensores indicados são os antagonistas do cálcio, os antagonistas serotoninérgicos, os diuréticos e os antagonistas alfa-1-adrenérgicos. Os anti-hipertensores contra-indicados são os antagonistas beta-adrenérgicos. Os anti-hipertensores a usar com precauções acrescidas são os inibidores do enzima de conversão da angiotensina e os agonistas alfa-2-adrenérgicos.

Palavras-chave:
Hipertensão arterial
Obstrução brônquica
Tratamento medicamentoso
ABSTRACT

Arterial hypertension and bronchial obstruction are very commun diseases in the population, it is indeed not rare that both conditions exist in the same person. It is fundamental to treat each one of them without aggravating the other. Concerning the treatment of hypertension there are in fact drugs that aggravate or cause bronchial obstruction and should be used with great precaution or even be contra-indicated.

In this paper considering bronchial obstruction the indicated anti-hypertensive drugs are calcium channel blockers. serotonin antagonists, diuretics and the alpha 1 antagonist drugs. The contra-indicated anti-hypertensive drugs are the beta blockers. The anti-hypertensive drugs to be used with great precaution are the angiotensin-converting enzyme inhibitors and alpha 2 agoinst drugs.

Key-Words:
Arterial hypertension
Bronchial obstruction
Drug therapy
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
Kaplan N.M. Clinical Hypenension. Fifth Edition.
[2.]
Fishman A.P. Pulmonary Diseases and Disorders. Second Edition.
[3.]
E.M. Mulloy, P. Cormie, J. Harvey, J.E. Marley.
Nitrendipine therapy in asthmatic subjects.
Br-J-Clin-Pharmacol, 30 (1990 Sep), pp. 493-495
[4.]
A.T. Dinh Xuan.
Asthme et traitements antihypertenseurs.
Rev. Mal. Resp., 6 (1989), pp. 295-301
[5.]
M. Cazzola, G. Damato, G. Lobefalo, B. Guillaro, J. Sepe, G. Assogna, R. Pietroletti, D. Lauria.
Ketanserin, a new blocking agent of Serotonin S2-Receprors. Respiratory functional effects in chronic obstruction of the airways.
Chest, (1987 Nov 5), pp. 863-866
[6.]
S. Bianco, M. Robuschi, A. Vaghi, M. Pasargiklian.
Prevention of exercise-induced bronchoconstriction by inhaled furosemide.
Lancet, ii (1988), pp. 252-255
[7.]
S. Bianco, M. Pieroni, M. Rufini, A. Sturman, M. Robuschj.
Inhaled furosemide prevents allergen induced bronchoconstriction in atopic asthmatics.
Am-Rev­Respir-Dis, 137 (1988), pp. 27
[8.]
M. Robuschi, A. Vaghi, G. Gombaso, S. Spagnatto, S. Bianco.
Inhaled furosemide is highly effective in preventing ultrasonically nebulized water bronhoconstriction.
Am-Rev-Respir-Dis, 137 (1988), pp. 412
[9.]
M. Cazzola, A. Spinazzi, G. Santangelo, V.W. Steinuans, W. Wurst, P. Solleder, G. Girbino.
Acute efects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease.
Drugs, 40 (1990), pp. 71-72
[10.]
J. Biernacki.
Doxazosin a new alpha 1 antagonist drug controls hypertension without causing arways obstruction in asthma and COPD.
J. Hum. Hypertens., 3 (1989), pp. 419-425
[11.]
S.H. Taylor.
Efficacy of doxazosin in specific hypertensive patient groups.
Am-Heart-J, 121 (1991 Jan), pp. 286-292
[12.]
I.M. James.
Which antihypertensive?.
Br-J-Clin Pract, 44 (1990 Mar), pp. 102-105
[13.]
R.S. Me Neill.
Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics.
Lancet, ii (1964), pp. 1101-1102
[14.]
M.K. Benson, W.T. Berril, J.M. Cruickshank, G.S. Sterling.
A comparison of four beta-adrenoceptor antagonists in patients with asthma.
Br-J-Clin-Pharmacol., 24 (1987), pp. 415-419
[15.]
G. Zaid, G.N. Beall.
Bronchial response to beta-adrenergic blockade.
N-Engl-J-Med, 275 (1966), pp. 580-584
[16.]
I.P. Williams, F.J. Millard.
Severe asthma after inadvert ingestion of oxprenolol.
Thorax, 35 (1980), pp. 160
[17.]
H. Lunde, T. Hedner, O. Samuelsson, J. Lotvall, L. Andren, L. Lindholm, B.E. Wiholm.
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
BMJ, 308 (1994 Jan 1), pp. 18-21
[18.]
J. Kaufmann, S. Schmitt, J. Barnard, W. Busse.
Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma.
Chest, 101 (1992 Apr), pp. 922-925
[19.]
W.H. Inman, L. Wilton, G. Pearce, R.D. Mann.
Angiotensin converting enzyme inhibitors and asthma.
BMJ, 308 (1994 Feb 26), pp. 593-594
[20.]
W.J. Elliott.
Antihypertensive therapy in a patient with gout and asthma.
JAMA, 271 (1994 Feb 16), pp. 555
Copyright © 1996. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?